GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
0
c/tirzepatide·posted 6 months ago by u/nabila_ogunleye

genuine question about SURPASS that I am slightly embarrassed to ask

Lab

Right, the SURPASS question again, but with numbers this time.

I have 10 data points over 22 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 7, not week 56. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

0 up / 0 down41% upvoted7 commentsid 1uv3q629 Jan 2026

7 comments

7 in this archive, depth 4

best — the order this archive was captured in

u/britt_okwuosa4 points·6 months ago

Crossposting this to c/glp1women because the people who need it are not reading this community.

replysharereportpermalink
u/nabila_ogunleyeOP2 points·6 months ago

Vial-splitting is on-topic here. Do not ask about pen-cracking, that goes in c/reconstitution.

replysharereportpermalink
u/britt_okwuosa1 point·6 months ago

the 15mg is the top of the pen, not the required dose

replysharereportpermalink
u/sten_bhattacharya1 point·6 months ago

How long at each step before you escalated?

replysharereportpermalink
u/b12_baseline1 point·6 months ago

do not crack the pen, we have been over this

replysharereportpermalink
u/nabila_ogunleyeOP3 points·6 months ago

Is that on Mounjaro pens or research tirzepatide?

replysharereportpermalink
u/marta_dziedzic1 point·6 months ago

Cosigning. The GIP contribution is real and the side effects are not simply scaled versions.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →